Companies / Netherlands
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Schering-Plough Acquires Organon
March 2007 | FDI AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
US drugmaker Schering-Plough has acquired Organon , the pharmaceuticals division of Dutch industrial conglomerate Akzo Nobel in a deal worth EUR11bn (US$14.5bn). The move has come as somewhat of a surprise, with the deal being announced on the same day that a planned initial public offering (IPO) for Organon was due to take place, with the aim of divesting a 30% stake.